It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Outcome prediction in critically ill patients under invasive ventilation remains extremely challenging. The driving pressure (ΔP) and the mechanical power of ventilation (MP) are associated with patient-centered outcomes like mortality and duration of ventilation. The objective of this study was to assess the predictive validity for mortality of the ΔP and the MP at 24 h after start of invasive ventilation.
Methods
This is a post hoc analysis of an observational study in intensive care unit patients, restricted to critically ill patients receiving invasive ventilation for at least 24 h. The two exposures of interest were the modified ΔP and the MP at 24 h after start of invasive ventilation. The primary outcome was 90-day mortality; secondary outcomes were ICU and hospital mortality. The predictive validity was measured as incremental 90-day mortality beyond that predicted by the Acute Physiology, Age and Chronic Health Evaluation (APACHE) IV score and the Simplified Acute Physiology Score (SAPS) II.
Results
The analysis included 839 patients with a 90-day mortality of 42%. The median modified ΔP at 24 h was 15 [interquartile range 12 to 19] cm H2O; the median MP at 24 h was 206 [interquartile range 145 to 298] 10−3 J/min/kg predicted body weight (PBW). Both parameters were associated with 90-day mortality (odds ratio (OR) for 1 cm H2O increase in the modified ΔP, 1.05 [95% confidence interval (CI) 1.03 to 1.08]; P < 0.001; OR for 100 10−3 J/min/kg PBW increase in the MP, 1.20 [95% CI 1.09 to 1.33]; P < 0.001). Area under the ROC for 90-day mortality of the modified ΔP and the MP were 0.70 [95% CI 0.66 to 0.74] and 0.69 [95% CI 0.65 to 0.73], which was neither different from that of the APACHE IV score nor that of the SAPS II.
Conclusions
In adult patients under invasive ventilation, the modified ΔP and the MP at 24 h are associated with 90 day mortality. Neither the modified ΔP nor the MP at 24 h has predictive validity beyond the APACHE IV score and the SAPS II.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Amsterdam, Amsterdam University Medical Centers, Department of Intensive Care, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)
2 University of Amsterdam, Amsterdam University Medical Centers, Department of Intensive Care, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262); Hospital Israelita Albert Einstein, Department of Critical Care Medicine, São Paulo, Brazil (GRID:grid.413562.7) (ISNI:0000 0001 0385 1941)
3 University of Amsterdam, Amsterdam University Medical Centers, Department of Intensive Care, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262); University of Amsterdam, Amsterdam University Medical Centers, Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)
4 University Medical Center Utrecht, Department of Intensive Care Medicine, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352)
5 University of Amsterdam, Amsterdam University Medical Centers, Center for Experimental and Molecular Medicine (CEMM), Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262); University of Amsterdam, Amsterdam University Medical Centers, Center for Infection and Immunity Amsterdam, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262); University of Amsterdam, Amsterdam University Medical Centers, Division of Infectious Diseases, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)
6 University of Amsterdam, Amsterdam University Medical Centers, Department of Intensive Care, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262); University of Amsterdam, Amsterdam University Medical Centers, Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262); Mahidol University, Mahidol–Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)